NEW YORK (360Dx) – A bipartisan bill has been introduced in the House of Representatives that would create tax credits covering half of the clinical testing costs incurred in the development of rapid diagnostics for certain infectious diseases.

The bill, introduced recently by Reps. Erik Paulsen of Minnesota and Mike Thompson of California, would amend the Internal Revenue Tax Code, and would also provide tax credits to cover half of the clinical testing expenses incurred in the development of drugs and therapeutics to treat certain serious or life-threatening infectious diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.